Form4insider filings, from the source

SEC Form 4 · accession 0001209191-15-086906

Calithera Biosciences, Inc. · CALA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Susan Molineaux
Officer — PRESIDENT AND CEO · Director
Period of report
Dec 21, 2015
Accepted (ET)
Dec 23, 2015 · 7:13 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Dec 21, 2015M4,367$0.48A85,654D
Common StockF1Dec 21, 2015M5,512$0.48A91,166D
Common StockF1Dec 21, 2015M6,306$0.96A97,472D
Common StockF1Dec 21, 2015M11,640$2.64A109,112D
Common Stockholding———117,962IBy Trust
Common Stockholding———39,542IBy Spouse

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Buy)F2$0.48Dec 21, 2015M4,367D—Dec 13, 2021Common Stock4,3670D
Employee Stock Option (Right to Buy)F3$0.48Dec 21, 2015M5,512D—Jun 12, 2022Common Stock5,5124,410D
Employee Stock Option (Right to Buy)F4$0.96Dec 21, 2015M6,306D—May 22, 2023Common Stock6,30622,703D
Employee Stock Option (Right to Buy)F5$2.64Dec 21, 2015M11,640D—Dec 16, 2023Common Stock11,64073,794D
Employee Stock Option (Right to Buy)F4$0.96Dec 21, 2015M5,418D—May 22, 2023Common Stock5,41819,506I
Employee Stock Option (Right to Buy)F5$2.64Dec 21, 2015M4,749D—Dec 16, 2023Common Stock4,74918,996I

Explanation of responses